• Je něco špatně v tomto záznamu ?

Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies

T. Reischig, M. Kacer, O. Hes, J. Machova, J. Nemcova, S. Kormunda, K. Pivovarcikova, M. Bouda,

. 2019 ; 34 (11) : 1970-1978. [pub] 20191101

Jazyk angličtina Země Velká Británie

Typ dokumentu klinické zkoušky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023553

BACKGROUND: Polyomavirus BK (BKV) infection of the renal allograft causes destructive tissue injury with inflammation and subsequent fibrosis. METHODS: Using a prospective cohort of patients after kidney transplantation performed between 2003 and 2012, we investigated the role of BKV viraemia in the development and progression of interstitial fibrosis and tubular atrophy (IFTA). The primary outcome was moderate-to-severe IFTA assessed by protocol biopsy at 36 months. RESULTS: A total of 207 consecutive recipients were enrolled. Of these, 57 (28%) developed BKV viraemia with 10 (5%) cases of polyomavirus-associated nephropathy (PVAN). Transient (<3 months) BKV viraemia occurred in 70% of patients, and persistent (≥3 months) BKV viraemia in 30%. A high viral load (≥10 000 copies/mL) was detected in 18% and a low viral load (<10 000 copies/mL) in 61%, while the viral load could not be determined in 21%. Moderate-to-severe IFTA was significantly increased in high [71%; odds ratio (OR) = 12.1; 95% confidence interval (CI) 1.62-90.0; P = 0.015] or persistent BKV viraemia (67%; OR = 6.33; 95% CI 1.19-33.7; P = 0.031) with corresponding rise in 'interstitial fibrosis + tubular atrophy' scores. Only patients with transient low BKV viraemia showed similar incidence and progression of IFTA to the no-BKV group. Persistent low BKV viraemia was uncommon yet the progression of fibrosis was significant. Only recipients with PVAN experienced inferior graft survival at 5 years. CONCLUSIONS: These data suggest that only transient low BKV viraemia does not negatively affect the progression of allograft fibrosis in contrast to excessive risk of severe fibrosis after high or persistent BKV viraemia.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023553
003      
CZ-PrNML
005      
20250402102440.0
007      
ta
008      
201125s2019 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/ndt/gfz061 $2 doi
035    __
$a (PubMed)31071208
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Reischig, Tomas $u Department of Internal Medicine I, Faculty of Medicine in Pilsen, Charles University, Czech Republic and Teaching Hospital, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
245    10
$a Viral load and duration of BK polyomavirus viraemia determine renal graft fibrosis progression: histologic evaluation of late protocol biopsies / $c T. Reischig, M. Kacer, O. Hes, J. Machova, J. Nemcova, S. Kormunda, K. Pivovarcikova, M. Bouda,
520    9_
$a BACKGROUND: Polyomavirus BK (BKV) infection of the renal allograft causes destructive tissue injury with inflammation and subsequent fibrosis. METHODS: Using a prospective cohort of patients after kidney transplantation performed between 2003 and 2012, we investigated the role of BKV viraemia in the development and progression of interstitial fibrosis and tubular atrophy (IFTA). The primary outcome was moderate-to-severe IFTA assessed by protocol biopsy at 36 months. RESULTS: A total of 207 consecutive recipients were enrolled. Of these, 57 (28%) developed BKV viraemia with 10 (5%) cases of polyomavirus-associated nephropathy (PVAN). Transient (<3 months) BKV viraemia occurred in 70% of patients, and persistent (≥3 months) BKV viraemia in 30%. A high viral load (≥10 000 copies/mL) was detected in 18% and a low viral load (<10 000 copies/mL) in 61%, while the viral load could not be determined in 21%. Moderate-to-severe IFTA was significantly increased in high [71%; odds ratio (OR) = 12.1; 95% confidence interval (CI) 1.62-90.0; P = 0.015] or persistent BKV viraemia (67%; OR = 6.33; 95% CI 1.19-33.7; P = 0.031) with corresponding rise in 'interstitial fibrosis + tubular atrophy' scores. Only patients with transient low BKV viraemia showed similar incidence and progression of IFTA to the no-BKV group. Persistent low BKV viraemia was uncommon yet the progression of fibrosis was significant. Only recipients with PVAN experienced inferior graft survival at 5 years. CONCLUSIONS: These data suggest that only transient low BKV viraemia does not negatively affect the progression of allograft fibrosis in contrast to excessive risk of severe fibrosis after high or persistent BKV viraemia.
650    _2
$a virus BK $x izolace a purifikace $x patogenita $7 D001739
650    _2
$a progrese nemoci $7 D018450
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibróza $x etiologie $x patologie $7 D005355
650    _2
$a přežívání štěpu $7 D006085
650    _2
$a lidé $7 D006801
650    _2
$a nemoci ledvin $x etiologie $x patologie $7 D007674
650    _2
$a transplantace ledvin $x škodlivé účinky $7 D016030
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a polyomavirové infekce $x komplikace $x virologie $7 D027601
650    _2
$a prospektivní studie $7 D011446
650    _2
$a homologní transplantace $7 D014184
650    _2
$a infekce onkogenními viry $x komplikace $x virologie $7 D014412
650    12
$a virová nálož $7 D019562
650    _2
$a viremie $x komplikace $x virologie $7 D014766
650    _2
$a replikace viru $7 D014779
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kacer, Martin $u Department of Internal Medicine I, Faculty of Medicine in Pilsen, Charles University, Czech Republic and Teaching Hospital, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Hes, Ondrej $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Czech Republic and Teaching Hospital, Pilsen, Czech Republic.
700    1_
$a Machova, Jana $u Department of Internal Medicine I, Faculty of Medicine in Pilsen, Charles University, Czech Republic and Teaching Hospital, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Nemcova, Jana $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Kormunda, Stanislav $u Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. Division of Information Technologies and Statistics, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
700    1_
$a Pivovarcikova, Kristyna $u Department of Pathology, Faculty of Medicine in Pilsen, Charles University, Czech Republic and Teaching Hospital, Pilsen, Czech Republic.
700    1_
$a Bouda, Mirko $u Department of Internal Medicine I, Faculty of Medicine in Pilsen, Charles University, Czech Republic and Teaching Hospital, Pilsen, Czech Republic. Biomedical Centre, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic. $7 xx0330644
773    0_
$w MED00010288 $t Nephrology, dialysis, transplantation $x 1460-2385 $g Roč. 34, č. 11 (2019), s. 1970-1978
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31071208 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20250402102437 $b ABA008
999    __
$a ok $b bmc $g 1595872 $s 1114229
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 34 $c 11 $d 1970-1978 $e 20191101 $i 1460-2385 $m Nephrology, dialysis, transplantation $n Nephrol Dial Transplant $x MED00010288
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Možnosti archivace